Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
The United Nations Millennium Development Goals galvanized global efforts to alleviate suffering of the world's poorest people through unprecedented public-private partnerships. Donor aid agencies have demonstrably saved millions of lives that might otherwise have been lost to disease through i...
Main Authors: | Vincent Ahonkhai, Samuel F Martins, Alexandre Portet, Murray Lumpkin, Dan Hartman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5112794?pdf=render |
Similar Items
-
Access to medicines for acute illness in middle income countries in Central America
by: Isabel Cristina Martins Emmerick, et al.
Published: (2013-12-01) -
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries.
by: Chaoyang Li, et al.
Published: (2024-01-01) -
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries
by: Chaoyang Li, et al.
Published: (2024-01-01) -
Limited access to CVD medicines in low-income and middle-income countries: poverty is at the heart of the matter
by: Charles Agyemang, et al.
Published: (2018-03-01) -
Access to innovative cancer medicines in a middle-income country - the case of Mexico
by: Daniela Moye-Holz, et al.
Published: (2018-12-01)